X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

XCUR

Closed

Exicure Inc

1.74
-0.13 (-6.95%)
Last Update: 06 Sep 2024 23:00:00
Yesterday: 1.87
Day's Range: 1.73 - 2.02
Send
When Written:
 
0.871
Exicure Inc is a clinical-stage biotechnology company that focuses on developing therapies based on its proprietary Spherical Nucleic Acid (SNA) technology. The company was founded in 2011 and is headquartered in Skokie, Illinois.

Exicure's SNA technology is designed to penetrate cells and tissues and target specific genes or proteins, which makes it a promising platform for developing treatments for a range of diseases, including cancer, inflammatory disorders, and genetic disorders.

The company's lead product candidate, AST-008, is being developed for the treatment of psoriasis and other inflammatory skin conditions. Exicure is also developing a pipeline of other SNA-based therapies, including treatments for cancer and genetic disorders.

Exicure has partnerships with several pharmaceutical companies, including Allergan, Eli Lilly, and Purdue Pharma, to develop SNA-based therapies. The company went public in 2018 and is listed on the Nasdaq stock exchange under the ticker symbol "XCUR."

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:3.137.180.181
X